Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131654) titled 'Clinical Experience and HealthEconomic Optimization Strategies of Teprotumumab N01 Injection in Thyroid Eye Disease' on Sept. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking University Shenzhen Hospital
Condition:
Thyroid-associated ophthalmopathy
eyelid retraction
proptosis
diplopia
Intervention:
Intravenous glucocorticoid (IVGC) treatment group:None
Orbital decompression surgery treatment group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-04
Target Sample Size: Intravenous glucocorticoid (IVGC) treatment group:20;Orbita...